{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:10:50Z","timestamp":1789665050689,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.pmr.2020.01.006","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T12:42:30Z","timestamp":1583930550000},"page":"265-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Opioid Management"],"prefix":"10.1016","volume":"31","author":[{"given":"W. Michael","family":"Hooten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmr.2020.01.006_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.pmr.2020.01.006_bib2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/pm\/pny307","article-title":"Challenges with implementing the centers for disease control and prevention opioid guideline: a consensus panel report","volume":"20","author":"Kroenke","year":"2019","journal-title":"Pain Med"},{"key":"10.1016\/j.pmr.2020.01.006_bib3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.mayocp.2016.04.029","article-title":"Chronic pain and mental health disorders: shared neural mechanisms, epidemiology, and treatment","volume":"91","author":"Hooten","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 1","key":"10.1016\/j.pmr.2020.01.006_bib4","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.pain.2013.09.001","article-title":"Pain matrices and neuropathic pain matrices: a review","volume":"154","author":"Garcia-Larrea","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.pmr.2020.01.006_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40122-017-0068-3","article-title":"The basic pharmacology of opioids informs the opioid discourse about misuse and abuse: a review","volume":"6","author":"Pergolizzi","year":"2017","journal-title":"Pain Ther"},{"key":"10.1016\/j.pmr.2020.01.006_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","article-title":"Opioid receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.pmr.2020.01.006_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jamapsychiatry.2018.0544","article-title":"Physician prescribing of opioids to patients at increased risk of overdose from benzodiazepine use in the United States","volume":"75","author":"Ladapo","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pmr.2020.01.006_bib8","doi-asserted-by":"crossref","first-page":"e198325","DOI":"10.1001\/jamanetworkopen.2019.8325","article-title":"Rates of physician coprescribing of opioids and benzodiazepines after the release of the centers for disease control and prevention guidelines in 2016","volume":"2","author":"Jeffery","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.pmr.2020.01.006_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00002508-200409000-00005","article-title":"Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain","volume":"20","author":"Keller","year":"2004","journal-title":"Clin J Pain"},{"key":"10.1016\/j.pmr.2020.01.006_bib10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11606-009-0981-1","article-title":"Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference","volume":"24","author":"Krebs","year":"2009","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.pmr.2020.01.006_bib11","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The patient health questionnaire-2: validity of a two-item depression screener","volume":"41","author":"Kroenke","year":"2003","journal-title":"Med Care"},{"key":"10.1016\/j.pmr.2020.01.006_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","article-title":"Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection","volume":"146","author":"Kroenke","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pmr.2020.01.006_bib13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.7326\/M16-0317","article-title":"Performance of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool for substance use screening in primary care patients","volume":"165","author":"McNeely","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pmr.2020.01.006_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5055\/jom.2015.0266","article-title":"Validation of a new risk assessment tool: the brief risk questionnaire","volume":"11","author":"Jones","year":"2015","journal-title":"J\u00a0Opioid Manag"},{"key":"10.1016\/j.pmr.2020.01.006_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jpainsymman.2006.03.010","article-title":"Validation and clinical application of the screener and opioid assessment for patients with pain (SOAPP)","volume":"32","author":"Akbik","year":"2006","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.pmr.2020.01.006_bib17","first-page":"1","article-title":"Beneficial opioid management strategies: a review of the evidence for the use of opioid treatment agreements","author":"McAuliffe Staehler","year":"2020","journal-title":"Subst Abus"},{"key":"10.1016\/j.pmr.2020.01.006_bib18","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.mayocp.2018.05.017","article-title":"CAREFUL: a practical guide for improving the clinical surveillance of long-term opioid therapy","volume":"93","author":"Hooten","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pmr.2020.01.006_bib19","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.amjmed.2012.12.001","article-title":"The effect of opioid therapy on endocrine function","volume":"126","author":"Brennan","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.pmr.2020.01.006_bib20","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.mayocp.2018.04.010","article-title":"Opioid-induced adrenal insufficiency","volume":"93","author":"Donegan","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pmr.2020.01.006_bib21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.mayocp.2015.04.003","article-title":"Tapering long-term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice","volume":"90","author":"Berna","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pmr.2020.01.006_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.genhosppsych.2017.04.011","article-title":"Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users","volume":"47","author":"Demidenko","year":"2017","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.pmr.2020.01.006_bib24","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s11606-019-05301-2","article-title":"Mortality after discontinuation of primary care-based chronic opioid therapy for pain: a retrospective cohort study","volume":"34","author":"James","year":"2019","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.pmr.2020.01.006_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11606-019-05227-9","article-title":"Opioid taper is associated with subsequent termination of care: a retrospective cohort study","volume":"35","author":"Perez","year":"2020","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.pmr.2020.01.006_bib26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jamainternmed.2017.8709","article-title":"Patient-centered prescription opioid tapering in community outpatients with chronic pain","volume":"178","author":"Darnall","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.pmr.2020.01.006_bib27","series-title":"Interagency guideline on\u00a0prescribing opioids for pain","year":"2015"},{"issue":"5","key":"10.1016\/j.pmr.2020.01.006_bib28","article-title":"Alpha(2)-adrenergic agonists for the management of opioid withdrawal","author":"Gowing","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pmr.2020.01.006_bib29","first-page":"169","article-title":"Safety and efficacy of lofexidine for medically managed opioid withdrawal: a randomized controlled clinical trial","volume":"13","author":"Fishman","year":"2019","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.pmr.2020.01.006_bib30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/JCP.0b013e31822bb378","article-title":"Importance of gabapentin dose in treatment of opioid withdrawal","volume":"31","author":"Salehi","year":"2011","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.pmr.2020.01.006_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0376-8716(99)00125-8","article-title":"Combined use of trazodone-naltrexone versus clonidine-naltrexone in rapid withdrawal from methadone treatment. A comparative inpatient study","volume":"59","author":"Pozzi","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pmr.2020.01.006_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/00952990.2011.644003","article-title":"The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal","volume":"38","author":"Mannelli","year":"2012","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.pmr.2020.01.006_bib33","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jcph.1449","article-title":"Loperamide: a readily available but dangerous opioid substitute","volume":"59","author":"White","year":"2019","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.pmr.2020.01.006_bib34","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/j.pain.0000000000000907","article-title":"Sustained improvements in pain, mood, function and opioid use post interdisciplinary pain rehabilitation in patients weaned from high and low dose chronic opioid therapy","volume":"158","author":"Huffman","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.pmr.2020.01.006_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/M17-0598","article-title":"Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review","volume":"167","author":"Frank","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pmr.2020.01.006_bib36","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/pm\/pny231","article-title":"Does opioid tapering in chronic pain patients result in improved pain or same pain vs increased pain at taper completion? A structured evidence-based systematic review","volume":"20","author":"Fishbain","year":"2019","journal-title":"Pain Med"}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965120300061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965120300061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T03:41:28Z","timestamp":1760931688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965120300061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1047965120300061"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2020.01.006","relation":{},"ISSN":["1047-9651"],"issn-type":[{"value":"1047-9651","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid Management","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2020.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}